Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017446
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2001-06-06
Brief Title:
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
Herbert Irving Comprehensive Cancer Center
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Phase II Evaluation Of CP4071 In Previously Treated Advanced Sarcomas
Status:
UNKNOWN
Status Verified Date:
2002-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
PURPOSE Phase II trial to study the effectiveness of CP4071 in treating patients who have locally advanced or metastatic soft tissue sarcoma
PURPOSE Phase II trial to study the effectiveness of CP4071 in treating patients who have locally advanced or metastatic soft tissue sarcoma
Detailed Description:
OBJECTIVES
Determine the efficacy in terms of response rate of CP4071 in patients with previously treated locally advanced or metastatic soft tissue sarcoma
Determine the clinical toxic effects of this drug in these patients
OUTLINE Patients receive oral CP4071 daily Treatment continues in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 25 patients will be accrued for this study
Determine the efficacy in terms of response rate of CP4071 in patients with previously treated locally advanced or metastatic soft tissue sarcoma
Determine the clinical toxic effects of this drug in these patients
OUTLINE Patients receive oral CP4071 daily Treatment continues in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 25 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CPMC-IRB-9825 | None | None | None |
| NCI-G01-1952 | None | None | None |